Clinical Trials Using Telotristat Etiprate

Clinical trials are research studies that involve people. The clinical trials on this list are studying Telotristat Etiprate. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants with Metastatic Well Differentiated Neuroendocrine Neoplasm

    This phase II trial studies how well telotristat etiprate works in treating participants with well differentiated neuroendocrine neoplasm that has spread to other places in the body and monitored by carbon C 11 alpha-methyltryptophan (AMT)-emission tomography (PET). Telotristat etiprate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Studying the changes within the tumor cells via AMT-PET may help doctors better understand how tumors respond to treatment with telotristat etiprate.
    Location: Wayne State University / Karmanos Cancer Institute, Detroit, Michigan